Wall Street learned on Tuesday that multinational pharmaceutical giant AstraZeneca has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after a suspected serious adverse reaction in a study participant. According to health news website, which quoted an AstraZeneca spokesperson, the “standard review process triggered a pause to vaccination to allow review … Continue reading “AstraZeneca Pauses Late Stage COVID-19 Vaccine Trial”
Biotech & Pharma
Inovio Pharmaceuticals Falls on Short Seller’s Comments About Coronavirus Hype
Inovio Pharmaceuticals shares were falling on Wednesday after short seller Muddy Waters revealed that it…
Nestlé Health Science to Acquire Aimmune Therapeutics to Create Global Leader in Food Allergy Prevention
Biopharmaceutical giant Nestlé announced that it will be acquiring Aimmune Therapeutics to create a global…
Moderna Reveals its Coronavirus Vaccine Has had Promising Results
Biotech company Moderna has revealed this week that its coronavirus vaccine has shown promising results…
Abbott Laboratories Scores U.S. Authorization for a Rapid Covid-19 Antigen
On Wednesday medical devices and healthcare company Abbott Laboratories announced that it has won U.S.…
Novartis Investigational Immuno-oncology Drug Fails Skin Cancer Trial
Swiss drug maker Novartis announced over the weeknd that the company's investigational spartalizumab immuno-oncology drug…
Johnson & Johnson to Start Late-stage Coronavirus Vaccine Trial Next Month
Johnson & Johnson announced on Thursday that it would begin largest, late-stage trial testing a…
Sanofi Agrees to Buy Principia Biopharma Inc. for Roughly $3.4 Billion
French multinational pharmaceutical company Sanofi has agreed to purchase U.S. biotech company Principia Biopharma Inc.…
Sorrento Shares Take Steep Fall as Company Fires CFO
According to a recent Securities and Exchange Commission filing, Sorrento has terminated its CFO Jiong…
President Trump Signs $1.5B Deal with Moderna for 100 Million Doses of Coronavirus Vaccine
This week President Trump announced that the U.S. government has signed a $1.5 billion deal…
Big Pharma Giant Merck Explodes on Earnings Beat
Shares of pharmaceutical firm Merck were heading higher after the company reported second-quarter sales of…
The United States Will Pay This Much to Pfizer and BioNTech for its COVID-19 Vaccine
As coronavirus cases keep surging, the U.S. is prepared to pay a steep amount for…
AstraZeneca’s Experimental COVID-19 Vaccine Looks Promising
With coronavirus cases surging in the U.S., many may feel relief learning that AstraZeneca's experimental…
Bioxcel Therapeutics Soars to Record High on Strong Schizophrenia Test Results
Shares of biotech company Bioxcel Therapeutics soared 14% on Monday and hit an all-time intraday…
